Basel Medical Group Ltd Ordinary Shares (BMGL) is a publicly traded Healthcare sector company. As of May 21, 2026, BMGL trades at $0.63 with a market cap of $12.39M and a P/E ratio of 0.00. BMGL moved +0.00% today. Year to date, BMGL is +9.49%; over the trailing twelve months it is -67.59%. Its 52-week range spans $0.49 to $9.40. Rallies surfaces BMGL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Basel Medical Resolves Nasdaq Filing Deficiency After March 13 Form 20-F Submission: Basel Medical filed an amended Form 20-F for fiscal 2025 on March 13, 2026, and Nasdaq staff confirmed compliance with Listing Rule 5250(c)(1). The resolution closes the prior periodic filing deficiency, reinstating the Company’s standing on The Nasdaq Stock Market.
| Metric | Value |
|---|---|
| Price | $0.63 |
| Market Cap | $12.39M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.40 |
| 52-Week Low | $0.49 |
| Volume | 2 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
BMGL analyst coverage data. Average price target: $0.00.